Medical The American pharmaceutical company Bristol-Myers Squibb 74 billion dollars for the acquisition of the Us biopharmaceutical company Celgene. The acquisition will create one of the world’s largest pharmaceutical companies.
The combined company is a leading producer of treatments for cancer, inflammation and autoimmune disorders. The new company will have nine products in their portfolio that are more than a billion dollars per year sell. The acquisition will Bristol-Myers Squibb, among others, the blockbuster cancer Revlimid in the hands. the
Including debt, calculations by the financial news agency Bloomberg, the recorddeal of 88 billion dollars.
